Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.
Journal of Dual Diagnosis includes articles and perspectives from four overarching domains relevant to the field: Psychopharmacology & Neurobiology; Psychotherapy & Psychosocial Issues; Services & Policy; and Clinical Forum. Each issue serves to encourage integration of these domains. The Journal seeks to publish articles relevant to a wide range of people interested in dual diagnosis: researchers, physicians, clinicians, trainees, administrators, and policy makers. High-quality empirical research, brief reports, timely reviews, thought-provoking commentaries, and ongoing discussions of clinical issues will be considered for publication, all with the aim of developing a better understanding of the basis of, and optimal treatment for, co-occurring psychiatric and substance use disorders.
Philadelphia Office: 530 Walnut Street, Suite 850 Philadelphia, PA 19106
Journal metrics
Usage
42K annual downloads/views
Citation metrics
1.5 (2023) Impact Factor
2.2 (2023) 5 year IF
4.9 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.919 (2023) SNIP
0.911 (2023) SJR
Speed/acceptance
51 days avg. from submission to first
decision
55 days avg. from submission to first
post-review decision
20 days avg. from acceptance to online
publication
52% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
E. Sherwood Brown, MD, PhD, MBA Professor and Aradine S. Ard Chair in Brain Science Vice Chairman for Clinical Research Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA Lou & Ellen McGinley Distinguished Chair in Psychiatric Research
MANAGING EDITOR
Emine Akar UT Southwestern Medical Center, Dallas, TX, USA
Genesis Gonzalez Alvarez Psychoneuroendocrine Research Group, UT Southwestern Medical Center, Dallas, TX, USA
Shuchi Lakhanpal Psychoneuroendocrine Research Group, UT Southwestern Medical Center, Dallas, TX, USA
ASSOCIATE EDITORS
Sinan Gülöksüz, MD., PhD Dept. Psychiatry and Neuropsychology, Maastricht University Medical Center, The Netherlands
Rajiv Radhakrishnan, MBBS, MD Assistant Professor of Psychiatry, Yale School of Medicine, New Haven, CT, USA
Laura Robinson, PhD School of Psychology, Faculty of the Arts, Social Sciences and Humanities (ASSH), University of Wollongong, Australia
Daniel Roche, PhD Assistant Professor of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
Matthew Sloan, MD, MSc Assistant Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
EDITORIAL BOARD
Caleb Adler, MD Associate Professor, Psychiatry and Neuroscience, University of Cincinnati, Cincinnati, OH, USA
Gary Bond, PhD Professor, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
Kathleen T. Brady, PhD Distinguished University Professor & Associate Provost Director, South Carolina Clinical and Translational Research Institute (SCTR), Charleston, SC, USA
Alan J. Budney, PhD Professor, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
Tom Burns, MD Professor, University of Oxford, Oxford, UK
R. Andrew Chambers, MD Associate Professor, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA
Tom Craig, MD, PhD Professor, Institute of Psychiatry, London, UK
Patricia E. Deegan, PhD Independent Consultant, Pat Deegan, PhD & Associates, LLC, Byfield, MA, USA
Deepak Cyril D'Souza, MD Associate Professor, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Director, Schizophrenia Research Program, VA Connecticut HealthCare System, West Haven, CT, USA
A. Eden Evins, MD, MPH Associate Professor, Department of Psychiatry, Harvard Medical School, Director, Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA, USA
Lindy Fox Smith, MA, LADC Mental Health and Substance Abuse Use Trainer/Consultant, LB FOX & Associates, LLC, Panama City Beach, FL, USA
Tony P. George, MD, FRCPC Professor, University of Toronto, Toronto, Canada
Christine E. Grella, PhD Professor, Department of Psychiatry & Biobehavioral Sciences, UCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA
Gillian Haddock, PhD Professor, University of Manchester, Manchester, UK
Andreas Heinz, MD Director and Chair, Department of Psychiatry, Charité - University Medical Center, Berlin, Germany
Elie Karam MD Professor & Head, Department of Psychiatry & Clinical Psychology, St. George Hospital University Medical Center, Beirut, Lebanon
David Kavanagh, PhD Professor, School of Psychology & Counselling and Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia
Peter Kelly, PhD Associate Professor of Psychology, University of Wollongong, Australia
Ronald C. Kessler, PhD Professor, Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
A. Thomas McLellan, PhD Chief Executive Officer, Treatment Research Institute, Philadelphia, PA, USA
Ingrid Melle, MD, PhD Professor, Institute of Clinical Medicine, Oslo, Norway
Chad D. Morris, PhD Professor, University of Colorado, Denver, CO, USA
Kim T. Mueser, PhD Executive Director, Center for Psychiatric Rehabilitation, Boston University, Boston, MA, USA
Mickael Naassila, PhD Professor, University of Picardie Jules Verne, Amiens, France
Lisa M. Najavits, PhD Professor, Boston University School of Medicine & Lecturer, Harvard Medical School, Boston, MA, USA
Vicki A. Nejtek, PhD Associate Professor, Department of Psychiatry and Behavioral Health and Director of Co-Occurring Disorders Research, University of North Texas Health Science Center, Fort Worth, TX, USA
Roger H. Peters, PhD Professor, Department of Mental Health Law and Policy, Louis de la Parte Florida Mental Health Institute, University of South Florida, Tampa, FL, USA
Stéphane Potvin, PhD Fernand-Seguin Research Center of Hôpital Louis-H. Lafontaine, Department of Psychiatry, Faculty of Medicine, University of Montréal, Montréal, Québec, Canada
Trevor W. Robbins, FRS, FMed Sci Professor, Department of Cognitive Neuroscience and Experimental Psychology (Head of Department) and Director, Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK
Robert A. Rosenheck, MD Professor, Department of Psychiatry, Public Health and the Child Study Center, Yale University School of Medicine, New Haven, CT, USA
David A. Smelson, PsyD Professor and Vice Chair, Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA
Roger D. Weiss, MD Professor, Department of Psychiatry, Harvard Medical School, Boston, MA, USA Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA, USA
Haiyi Xie, PhD Associate Professor, Department of Community & Family Medicine, Dartmouth Medical School, Lebanon, NH, USA
Douglas M. Ziedonis, MD, MPH Professor and Chairman, Department of Psychiatry, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, MA, USA
Abstracting and indexing
The Journal of Dual Diagnosis is abstracted/indexed in: PsycINFO, PubMed, ProQuest, E-Psyche, EMBASE, EBSCOhost, Clarivate Analytics and Adis International Ltd.
Open access
Journal of Dual Diagnosis is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110802/Subject-Sample-2021-Behavioral-Sciences.jpg"})
![F1000Research. The Health Services Gateway. Accepting multiple article types. Submit now.]({"type":"image" , "src" : "/sda/112414/JournalAd-F1000-HealthServices.jpg"})